Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Arena Pharmaceuticals, Inc. published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 19
» View courant.com items only
    May 24, 2013 |Story| Reuters

  1. Novo obesity drug could launch in U.S. end 2014

    Reuters
    COPENHAGEN (Reuters) - Danish drug maker Novo Nordisk said it could launch obesity treatment liraglutide in the United States by the end of next year and rejected some analysts' doubts over the medicine's commercial potential. The world's biggest insulin...

    Tags: Diabetes, Qsymia, Weight, Insulin Injections, Vivus Inc.

    2. May 9, 2013 |Story| Reuters

  2. ANALYSIS-A hard day to be a short-seller, one of many this year

    Reuters
    By Ryan Vlastelica NEW YORK, May 9 (Reuters) - Three long-time favorites of the short-selling crowd are making those investors eat crow, as Tesla, Barnes & Noble and Green Mountain Coffee are racking up big gains, making an already painful year for...

    Tags: Tesla Motors, Inc., Central Bank, Manufacturing and Engineering, Microsoft Corporation, Barnes & Noble

    3. May 3, 2013 |Story| Reuters

  3. U.S. RESEARCH ROUNDUP: Estee Lauder, Actavis, MGM Resorts

    Reuters
    May 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Estee Lauder and MGM Resorts, on Friday. HIGHLIGHTS * LinkedIn Corp : BMO, JP Morgan, Canaccord Genuity, others raise...

    Tags: Madison Square Garden, Rent-A-Center Incorporated, Procera Networks, SYSCO Corporation, CenterPoint Energy Incorporated

    4. May 2, 2013 |Story| Reuters

  4. BRIEF-Arena Pharmaceuticals shares fall 14 pct after the bell following results

    Reuters
    NEW YORK, May 2 (Reuters) - Arena Pharmaceuticals Inc : * Shares fell 14 percent after the bell following the release of its results.

    Tags: Drugs and Medicines

    5. Jun 27, 2012 |Story| Los Angeles Times

  5. FDA approves lorcaserin, first weight-loss drug since 1999

    The Food and Drug Administration has approved marketing of the weight-loss drug lorcaserin, the first prescription anti-obesity medication to win the FDA's blessing since the agency approved orlistat in 1999.
    The Food and Drug Administration has approved marketing of the weight-loss drug lorcaserin, the first prescription anti-obesity medication to win the FDA's blessing since the agency approved orlistat in 1999. Once it is cleared by the Drug Enforcement...

    Tags: Massachusetts General Hospital, High Blood Pressure, Cancer, Heart Disease, Obesity

    6. Jun 28, 2012 |Story| KTLA-LTV

  6. FDA Approves Diet Drug to Treat Overweight Adults

    NEW YORK -- Some people who suffer from chronic weight issues may soon get some help from a pill.　
    CNN
    NEW YORK -- Some people who suffer from chronic weight issues may soon get some help from a pill.　 The U.S. Food and Drug Administration Wednesday approved Belviq, or lorcaserin hydrochloride, to be combined with a reduced-calorie diet and...

    Tags: Diabetes, Weight, Diseases and Illnesses, High Blood Pressure, Physical Fitness and Exercise

    7. Jun 27, 2012 |Story| CNN

  7. FDA approves 1st new diet drug in 13 years

    SAN DIEGO -- The U.S. Food and Drug Administration Wednesday approved a new diet drug from San Diego's Arena Pharmaceuticals. It's the first diet drug approved in more than  a decade.
    SAN DIEGO -- The U.S. Food and Drug Administration Wednesday approved a new diet drug from San Diego's Arena Pharmaceuticals. It's the first diet drug approved in more than  a decade. Belviq, or lorcaserin hydrochloride is to be combined with a reduced-...

    Tags: Diabetes, Diseases and Illnesses, Weight, Pharmaceuticals, High Blood Pressure

    8. Mar 29, 2012 |Story| Reuters

  8. Obesity drugs need heart studies, U.S. advisers say

    SILVER SPRING, Maryland (Reuters) - Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs' approval.
    Reuters
    SILVER SPRING, Maryland (Reuters) - Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs' approval. An advisory panel to the U.S. Food and Drug Administration...

    Tags: High Blood Pressure, Stroke, Heart Disease, Obesity, Qsymia

    9. Sep 7, 2011 |Story| Reuters

  9. Starbucks CEO campaigns to end Washington gridlock

    Reuters
    Starbucks Corp Chief Executive Howard Schultz called on Americans on Tuesday to deluge U.S. lawmakers with demands to end the partisan gridlock that he said is paralyzing Washington. Schultz also urged lawmakers to focus on issues such as job creation...

    Tags: Labor Markets, Business Enterprises, Career and Workplace, Justice System, JC Penney Company Inc.

    10. Oct 25, 2010 |Story| Los Angeles Times

  10. FDA shoots down another weight loss drug [Updated]

    The FDA has <a title="Arena Pharmaceuticals' press release" href="http://invest.arenapharm.com/releasedetail.cfm?ReleaseID=521977" target="_blank">told the makers</a> of the proposed weight-loss drug Lorcaserin&nbsp;that it will not&nbsp;at this time approve the marketing of &nbsp;the medication, citing concerns about its marginal effectiveness and about&nbsp;cancers that occurred at higher-than-usual rates in animal studies. [<b>Updated Oct. 25, 10:35 a.m.</b> An earlier version of this article said cancers occurred at higher-than-usual-rates during clinical trials.]
    The FDA has told the makers of the proposed weight-loss drug Lorcaserin that it will not at this time approve the marketing of  the medication, citing concerns about its marginal effectiveness and about cancers that occurred at higher-than-usual rates...

    Tags: Los Angeles Times, Diabetes, Weight, Crime, Law and Justice, Pharmaceuticals

    11. Sep 15, 2010 |Story| Chicago Tribune

  11. Diet drugs face tough test

    There has never been a magic prescription to help millions of obese Americans lose weight. Whether one is any closer to reality is now under scrutiny.
    Tribune Newspapers
    There has never been a magic prescription to help millions of obese Americans lose weight. Whether one is any closer to reality is now under scrutiny. A Food and Drug Administration advisory panel will decide Wednesday whether the diet drug Meridia...

    Tags: Health Organizations, High Blood Pressure, Obesity, Physical Conditions, Northwestern University

    12. Oct 29, 2010 |Story| Associated Press
  12. |Story

    Tags: Diabetes, Weight, Companies and Corporations, Mountain View (Santa Clara, California), Health and Medical Professionals

 1  2 • Next >
Original site for Arena Pharmaceuticals, Inc. topic gallery.